Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
LifeTech Scientific Corporation ( (HK:1302) ) has provided an update.
LifeTech Scientific Corporation has announced a board meeting scheduled for March 28, 2025, to discuss and approve the audited annual results for the year ending December 31, 2024. The meeting will also consider a final dividend recommendation, the closure of the register of members, and details of the forthcoming annual general meeting. This announcement signifies the company’s ongoing commitment to transparency and shareholder engagement, potentially impacting its financial strategies and stakeholder relations.
More about LifeTech Scientific Corporation
LifeTech Scientific Corporation is a company incorporated in the Cayman Islands, operating in the medical technology industry. It focuses on developing and manufacturing medical devices, with a particular emphasis on cardiovascular and peripheral vascular disease treatment solutions.
YTD Price Performance: 18.71%
Average Trading Volume: 23,103,778
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$7.12B
For an in-depth examination of 1302 stock, go to TipRanks’ Stock Analysis page.